(VIANEWS) – New York Mortgage Trust (NYMT), Ebix (EBIX), Donegal Group (DGICB) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| New York Mortgage Trust (NYMT) | 15% | 2023-11-04 15:46:05 |
| Ebix (EBIX) | 8.44% | 2023-11-14 12:11:53 |
| Donegal Group (DGICB) | 4.38% | 2023-11-02 07:12:08 |
| CNB Financial Corporation (CCNE) | 3.85% | 2023-11-01 15:23:07 |
| Vaxart (VXRT) | 3.63% | 2023-11-12 16:07:10 |
| Popular (BPOP) | 3.38% | 2023-11-01 10:17:06 |
| Darden Restaurants (DRI) | 3.36% | 2023-11-14 12:54:34 |
| Harvard Bioscience (HBIO) | 2.43% | 2023-11-03 07:41:06 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. New York Mortgage Trust (NYMT) – Dividend Yield: 15%
New York Mortgage Trust’s last close was $8.00, 38.27% under its 52-week high of $12.96. Intraday change was 2.17%.
New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. Its targeted investments include residential loans, second mortgages, and business purpose loans; structured multi-family property investments, such as preferred equity in, and mezzanine loans to owners of multi-family properties, as well as joint venture equity investments in multi-family properties; non-agency residential mortgage-backed securities (RMBS); agency RMBS; commercial mortgage-backed securities (CMBS); and other mortgage, residential housing, and credit-related assets. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, New York Mortgage Trust has a trailing twelve months EPS of $-1.85.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.55%.
Yearly Top and Bottom Value
New York Mortgage Trust’s stock is valued at $8.00 at 04:15 EST, way below its 52-week high of $12.96 and way higher than its 52-week low of $7.23.
Volume
Today’s last reported volume for New York Mortgage Trust is 812515 which is 21.48% above its average volume of 668828.
Sales Growth
New York Mortgage Trust’s sales growth is negative 27% for the ongoing quarter and 5.7% for the next.
More news about New York Mortgage Trust.
2. Ebix (EBIX) – Dividend Yield: 8.44%
Ebix’s last close was $3.39, 89.7% below its 52-week high of $32.87. Intraday change was 8.42%.
Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.
Earnings Per Share
As for profitability, Ebix has a trailing twelve months EPS of $1.09.
PE Ratio
Ebix has a trailing twelve months price to earnings ratio of 3.37. Meaning, the purchaser of the share is investing $3.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.
More news about Ebix.
3. Donegal Group (DGICB) – Dividend Yield: 4.38%
Donegal Group’s last close was $13.94, 30.92% under its 52-week high of $20.18. Intraday change was 4.03%.
Donegal Group Inc., an insurance holding company, provides personal and commercial lines of property and casualty insurance to businesses and individuals in the Mid-Atlantic, Midwestern, New England, and southern states. It operates through four segments: Investment Function, Personal Lines of Insurance, and Commercial Lines of Insurance. The company offers private passenger automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents, as well as protection against loss from damage to automobiles. It also offers homeowners policies, which provide coverage for damage to residences and their contents from a range of perils, including fire, lightning, windstorm, and theft; and liability of the insured arising from injury to other persons or their property. In addition, the company offers commercial automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents and protection against loss from damage to automobiles owned by the insured; commercial multi-peril policies that provide protection to businesses against various perils, primarily combining liability and physical damage coverages; and workers' compensation policies, which provide benefits to employees for injuries sustained during employment. The company markets its insurance products through a network of approximately 2,400 independent insurance agencies. Donegal Group Inc. was founded in 1986 and is headquartered in Marietta, Pennsylvania.
Earnings Per Share
As for profitability, Donegal Group has a trailing twelve months EPS of $0.31.
PE Ratio
Donegal Group has a trailing twelve months price to earnings ratio of 44.97. Meaning, the purchaser of the share is investing $44.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.07%.
More news about Donegal Group.
4. CNB Financial Corporation (CCNE) – Dividend Yield: 3.85%
CNB Financial Corporation’s last close was $18.18, 31.65% below its 52-week high of $26.60. Intraday change was 1.71%.
CNB Financial Corporation operates as the bank holding company for CNB Bank that provides a range of banking products and services for individual, business, governmental, and institutional customers. The company accepts checking, savings, and time deposit accounts; and offers real estate, commercial, industrial, residential, and consumer loans, as well as various other specialized financial services. It also provides wealth and asset management services, including the administration of trusts and estates, retirement plans, and other employee benefit plans, as well as a range of wealth management services. In addition, the company invests in debt and equity securities; sells nonproprietary annuities and other insurance products; and small balance unsecured loans and secured loans primarily collateralized by automobiles and equipment. As of February 8, 2022, the company operated a private banking division; three loan production office; one drive-up office; and 45 full-service offices in Pennsylvania, Ohio, New York, and Virginia. CNB Financial Corporation was founded in 1865 and is headquartered in Clearfield, Pennsylvania.
Earnings Per Share
As for profitability, CNB Financial Corporation has a trailing twelve months EPS of $2.61.
PE Ratio
CNB Financial Corporation has a trailing twelve months price to earnings ratio of 7.08. Meaning, the purchaser of the share is investing $7.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.25%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 38.9% and a negative 27.1%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.8%, now sitting on 218.47M for the twelve trailing months.
More news about CNB Financial Corporation.
5. Vaxart (VXRT) – Dividend Yield: 3.63%
Vaxart’s last close was $0.75, 56.65% under its 52-week high of $1.73. Intraday change was 2.59%.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which has completed Phase I clinical trials with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trials for treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine. It is also developing therapeutic immune-oncology vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. Vaxart, Inc. is headquartered in South San Francisco, California.
Earnings Per Share
As for profitability, Vaxart has a trailing twelve months EPS of $-0.63.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -91.84%.
Volatility
Vaxart’s last week, last month’s, and last quarter’s current intraday variation average was 0.91%, 0.73%, and 3.15%.
Vaxart’s highest amplitude of average volatility was 3.65% (last week), 2.92% (last month), and 3.15% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Vaxart’s EBITDA is 105.78.
Moving Average
Vaxart’s worth is higher than its 50-day moving average of $0.72 and under its 200-day moving average of $0.83.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 8, 2012, the estimated forward annual dividend yield is 3.63%.
More news about Vaxart.
6. Popular (BPOP) – Dividend Yield: 3.38%
Popular’s last close was $62.75, 15.2% below its 52-week high of $74.00. Intraday change was 0.03%.
Popular, Inc., through its subsidiaries, provides various retail, mortgage, and commercial banking products and services in Puerto Rico, the United States, and British Virgin Islands. The company provides savings, NOW, money market, and other interest-bearing demand accounts; non-interest bearing demand deposits; and certificates of deposit. It also offers commercial and industrial, commercial multi-family, commercial real estate, and residential mortgage loans; consumer loans, including personal loans, credit cards, automobile loans, home equity lines of credit, and other loans to individual borrowers; construction loans; and lease financing comprising automobile loans/leases. In addition, the company provides investment banking, auto and equipment leasing and financing, broker-dealer, and insurance services; debit cards; and online banking services. As of December 31, 2021, it operated 169 branches; and 616 ATMs in Puerto Rico, 23 ATMs in the Virgin Islands, and 91 ATMs in the United States Mainland. Popular, Inc. was founded in 1893 and is headquartered in Hato Rey, Puerto Rico.
Earnings Per Share
As for profitability, Popular has a trailing twelve months EPS of $9.77.
PE Ratio
Popular has a trailing twelve months price to earnings ratio of 6.66. Meaning, the purchaser of the share is investing $6.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.31%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 32.3%, now sitting on 2.62B for the twelve trailing months.
More news about Popular.
7. Darden Restaurants (DRI) – Dividend Yield: 3.36%
Darden Restaurants’s last close was $151.25, 12.6% below its 52-week high of $173.06. Intraday change was 1.77%.
Darden Restaurants, Inc., through its subsidiaries, owns and operates full-service restaurants in the United States and Canada. It operates under Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Yard House, The Capital Grille, Seasons 52, Bahama Breeze, Eddie V's Prime Seafood, and Capital Burger brands. Darden Restaurants, Inc. was founded in 1968 and is based in Orlando, Florida.
Earnings Per Share
As for profitability, Darden Restaurants has a trailing twelve months EPS of $8.05.
PE Ratio
Darden Restaurants has a trailing twelve months price to earnings ratio of 19.12. Meaning, the purchaser of the share is investing $19.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.76%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 10.77B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Darden Restaurants’s stock is considered to be oversold (<=20).
More news about Darden Restaurants.
8. Harvard Bioscience (HBIO) – Dividend Yield: 2.43%
Harvard Bioscience’s last close was $4.30, 31.64% below its 52-week high of $6.29. Intraday change was 3.37%.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Earnings Per Share
As for profitability, Harvard Bioscience has a trailing twelve months EPS of $-0.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.1%.
Sales Growth
Harvard Bioscience’s sales growth is negative 3% for the present quarter and 7.5% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Harvard Bioscience’s EBITDA is 1.21.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.5%, now sitting on 114.08M for the twelve trailing months.
More news about Harvard Bioscience.
